US 11582956
Recombinant adenovirus-based interferon biotherapeutics in swine
granted A61KA61K48/005
Quick answer
US patent 11582956 (Recombinant adenovirus-based interferon biotherapeutics in swine) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K48/005